| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.4 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |